We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Acyl Amides May Lead to New Drugs to Treat Osteoporosis

By LabMedica International staff writers
Posted on 11 Oct 2010
The discovery that a class of compounds known as acyl amides is critically involved in maintaining bone density balance may pave the way for a new generation of drugs to treat osteoporosis.

Bone mass and shape are continuously remodeled by the concerted and balanced action of osteoblasts (bone forming cells) and osteoclasts (bone-resorbing cells). More...
The endocannabinoid system plays an essential role in the maintenance of normal bone mass via signaling through the CB2 (cannabinoid receptor 2) receptor. One of the substances now being studied for its role in bone metabolism is N-oleoyl-L-serine (OS), an endogenous lipid (of the acyl amide class) that has been reported to stimulate bone formation and to inhibit bone resorption.

Investigators at the Hebrew University of Jerusalem (Israel) worked with the mouse ovariectomy (OVX) model of osteoporosis. They compared the effects of treating OVX mice with OS to those obtained by treating a normal control group. Results published in the September 27, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) revealed that in normal mice, OS moderately increased bone volume density mainly by inhibiting bone resorption. However, in OVX mice, OS effectively reversed bone loss by increasing bone formation and markedly restraining bone resorption.

The differential effect of exogenous OS in the OVX vs. intact animals was thought to be due to the lack of OS in the bones of the OVX animals.

The investigators hope to adapt OS or a similar substance for drug use, since up to now drugs for treatment of osteoporosis have worked to prevent further bone loss or to encourage bone formation, but none of them has been able to accomplish both functions together.

Related Links:

Hebrew University of Jerusalem





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Thyroid Test
Anti-Thyroid EIA Test
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.